| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10715762.2015.1078461 |
| P698 | PubMed publication ID | 26223319 |
| P2093 | author name string | N U Ashraf | |
| T A Sheikh | |||
| P2860 | cites work | Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets. | Q51543585 |
| The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease. | Q51757172 | ||
| Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. | Q51767284 | ||
| Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance. | Q53181684 | ||
| Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. | Q53543252 | ||
| Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity. | Q54318425 | ||
| Vitamin E: action, metabolism and perspectives | Q56038941 | ||
| ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs | Q24290776 | ||
| CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells | Q24301679 | ||
| Roles of CHOP/GADD153 in endoplasmic reticulum stress | Q24302185 | ||
| Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER | Q24305459 | ||
| Endoplasmic reticulum stress: cell life and death decisions. | Q24536108 | ||
| JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis | Q24554008 | ||
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis | Q24625697 | ||
| Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis | Q24631468 | ||
| Endoplasmic reticulum stress and the inflammatory basis of metabolic disease | Q24633352 | ||
| Atf4 regulates obesity, glucose homeostasis, and energy expenditure | Q24648259 | ||
| Oxidative protein folding in eukaryotes: mechanisms and consequences | Q24676827 | ||
| Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease | Q26853645 | ||
| The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling | Q27008029 | ||
| Endoplasmic reticulum stress in nonalcoholic fatty liver disease | Q38027194 | ||
| Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration | Q38073952 | ||
| Nonalcoholic fatty liver disease: current issues and novel treatment approaches | Q38074898 | ||
| Involvement of free radicals and oxidative stress in NAFLD/NASH. | Q38134169 | ||
| Nox NADPH oxidases and the endoplasmic reticulum | Q38175423 | ||
| Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes | Q38194332 | ||
| Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice | Q38292063 | ||
| Metformin reverses fatty liver disease in obese, leptin-deficient mice | Q38308602 | ||
| Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis | Q38310080 | ||
| NADPH Oxidases in Chronic Liver Diseases | Q38599090 | ||
| Oxidative stress mediated Ca(2+) release manifests endoplasmic reticulum stress leading to unfolded protein response in UV-B irradiated human skin cells | Q38998669 | ||
| GRP78 suppresses lipid peroxidation and promotes cellular antioxidant levels in glial cells following hydrogen peroxide exposure. | Q39029371 | ||
| Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? | Q39472674 | ||
| Bip overexpression, but not CHOP inhibition, attenuates fatty-acid-induced endoplasmic reticulum stress and apoptosis in HepG2 liver cells | Q39640835 | ||
| Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study | Q39880419 | ||
| Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice | Q39975807 | ||
| A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. | Q40464366 | ||
| Novel role for JNK as a stress-activated Bcl2 kinase | Q40809860 | ||
| Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish | Q41764630 | ||
| The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis | Q41904044 | ||
| UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. | Q42041480 | ||
| Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis | Q42117714 | ||
| Regulation of apoptosis by the unfolded protein response. | Q42159220 | ||
| IRE1, a double-edged sword in pre-miRNA slicing and cell death | Q42159223 | ||
| Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress | Q42451739 | ||
| A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease | Q42654018 | ||
| Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling | Q43073146 | ||
| Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis | Q43217282 | ||
| Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial | Q43265559 | ||
| Metformin in non-alcoholic steatohepatitis. | Q43745120 | ||
| Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease | Q43892211 | ||
| Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients | Q44615824 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor | Q45200756 | ||
| A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial. | Q46008293 | ||
| Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia | Q46243154 | ||
| Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis | Q46418008 | ||
| Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial | Q46575030 | ||
| Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase | Q46577535 | ||
| Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis | Q46751757 | ||
| CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury | Q46823993 | ||
| Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. | Q46955928 | ||
| Role of diet and nutritional management in non-alcoholic fatty liver disease. | Q50468162 | ||
| Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. | Q51381016 | ||
| Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. | Q51442516 | ||
| Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. | Q51500156 | ||
| Regulated Ire1-dependent decay of messenger RNAs in mammalian cells | Q37309146 | ||
| Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase | Q37456875 | ||
| Lipid peroxidation: physiological levels and dual biological effects | Q37509376 | ||
| Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells. | Q37691228 | ||
| Endoplasmic reticulum stress and lipid dysregulation | Q37834712 | ||
| Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease | Q37844020 | ||
| The signalling from endoplasmic reticulum-resident bZIP transcription factors involved in diverse cellular physiology | Q37860033 | ||
| The role of oxidative stress in non-alcoholic steatohepatitis | Q37868177 | ||
| Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role | Q37887977 | ||
| Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic | Q37946188 | ||
| Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis | Q37953770 | ||
| Redox signaling loops in the unfolded protein response | Q38000454 | ||
| The SREBP pathway--insights from Insigs and insects | Q34223258 | ||
| Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response | Q34253691 | ||
| A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis | Q34585893 | ||
| The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis | Q34617479 | ||
| HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes | Q34637857 | ||
| Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial | Q35031127 | ||
| Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease | Q35055531 | ||
| The cell biology of the unfolded protein response. | Q35085852 | ||
| SREBPs: transcriptional mediators of lipid homeostasis | Q35176927 | ||
| A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. | Q35222087 | ||
| Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition | Q35562084 | ||
| Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. | Q35907138 | ||
| Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). | Q35963951 | ||
| Endoplasmic reticulum stress in liver disease | Q36031838 | ||
| Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver | Q36055803 | ||
| Stearic acid accumulation in macrophages induces toll-like receptor 4/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis. | Q36065244 | ||
| Resveratrol: French paradox revisited | Q36099455 | ||
| Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
| Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism | Q36199008 | ||
| Review article: role of oxidative stress in the progression of non-alcoholic steatosis | Q36286331 | ||
| Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. | Q36365999 | ||
| IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis | Q36600595 | ||
| Transmembrane bZIP transcription factors in ER stress signaling and the unfolded protein response | Q36948672 | ||
| Endoplasmic reticulum stress and liver injury | Q36989688 | ||
| Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? | Q36989869 | ||
| Endoplasmic reticulum stress responses | Q37014237 | ||
| How IRE1 reacts to ER stress | Q37055568 | ||
| Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss | Q37105351 | ||
| ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. | Q37132127 | ||
| GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice | Q37170811 | ||
| From endoplasmic-reticulum stress to the inflammatory response | Q37225354 | ||
| ATF6 modulates SREBP2-mediated lipogenesis. | Q37260315 | ||
| NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? | Q37269522 | ||
| Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis | Q37299002 | ||
| ER stress-induced cell death mechanisms | Q27027638 | ||
| The stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesis | Q27319729 | ||
| Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
| Ero1p: a novel and ubiquitous protein with an essential role in oxidative protein folding in the endoplasmic reticulum | Q27939552 | ||
| The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor | Q28238069 | ||
| Development of a novel ER stress based selection system for the isolation of highly productive clones | Q28264704 | ||
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology | Q28267844 | ||
| Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1 | Q28276509 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| SREBP transcription factors: master regulators of lipid homeostasis | Q28297603 | ||
| PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation | Q28507769 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress | Q28511471 | ||
| Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha | Q28512201 | ||
| Polymorphism of rs1836882 in NOX4 gene modifies associations between dietary caloric intake and ROS levels in peripheral blood mononuclear cells | Q28538210 | ||
| Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state | Q28572472 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis | Q28586997 | ||
| Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies | Q28611460 | ||
| The unfolded protein response: from stress pathway to homeostatic regulation | Q29547396 | ||
| SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | Q29547646 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress | Q29615495 | ||
| The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 | ||
| ER stress triggers apoptosis by activating BH3-only protein Bim | Q29617730 | ||
| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29620308 | ||
| Mitochondrial abnormalities in non-alcoholic steatohepatitis | Q30304277 | ||
| Resveratrol inhibits nonalcoholic fatty liver disease in rats | Q33368294 | ||
| NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease | Q33583595 | ||
| BiP binding to the ER-stress sensor Ire1 tunes the homeostatic behavior of the unfolded protein response | Q33631257 | ||
| Role of NADPH oxidases in liver fibrosis | Q33632736 | ||
| Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats | Q33782820 | ||
| Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease | Q33828303 | ||
| Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway | Q34128069 | ||
| Pathological aspects of lipid peroxidation. | Q34137628 | ||
| Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention | Q34162955 | ||
| P433 | issue | 12 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| endoplasmic reticulum | Q79927 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 1405-1418 | |
| P577 | publication date | 2015-07-30 | |
| P1433 | published in | Free Radical Research | Q5500025 |
| P1476 | title | Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease | |
| P478 | volume | 49 |
| Q30832471 | Acute accumulation of free cholesterol induces the degradation of perilipin 2 and Rab18-dependent fusion of ER and lipid droplets in cultured human hepatocytes |
| Q90092754 | Aldehyde Dehydrogenase, Liver Disease and Cancer |
| Q47104903 | Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate |
| Q103004751 | Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study |
| Q41595515 | Calcitriol exerts an anti-tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response |
| Q41912442 | Chemical chaperone 4-phenyl butyric acid (4-PBA) reduces hepatocellular lipid accumulation and lipotoxicity through induction of autophagy |
| Q39487830 | Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. |
| Q60917251 | Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice |
| Q91853183 | Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress |
| Q47680877 | Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. |
| Q90537775 | Double Knockout of Peroxiredoxin 4 (Prdx4) and Superoxide Dismutase 1 (Sod1) in Mice Results in Severe Liver Failure |
| Q42362670 | Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver disease |
| Q55456504 | Endoplasmic Reticulum Stress in Metabolic Disorders. |
| Q92581837 | Erythropoietin suppresses hepatic steatosis and obesity by inhibiting endoplasmic reticulum stress and upregulating fibroblast growth factor 21 |
| Q90464416 | FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity |
| Q91751735 | GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury |
| Q92059925 | Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease |
| Q92932433 | Hepatic stress associated with pathologies characterized by disturbed glucose production |
| Q28074455 | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? |
| Q48183802 | Inorganic arsenic causes fatty liver and interacts with ethanol to cause alcoholic liver disease in zebrafish |
| Q37063273 | Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice |
| Q90472043 | Kinetics of Glutathione Depletion and Antioxidant Gene Expression as Indicators of Chemical Modes of Action Assessed in Vitro in Mouse Hepatocytes with Enhanced Glutathione Synthesis |
| Q39452331 | Lipid droplet functions beyond energy storage |
| Q37587055 | Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility |
| Q49438485 | Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis |
| Q46606298 | Mdivi-1 Protects Epileptic Hippocampal Neurons from Apoptosis via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress in Vitro |
| Q92771982 | Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China |
| Q58604208 | Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease |
| Q37619863 | New insights into the unfolded protein response in stem cells |
| Q49959253 | Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. |
| Q90416246 | Nonalcoholic Fatty Liver Disease |
| Q89975927 | Oxidative Stress and Endoplasmic Reticulum Stress Are Involved in the Protective Effect of Alpha Lipoic Acid Against Heat Damage in Chicken Testes |
| Q54110224 | Oxymatrine Causes Hepatotoxicity by Promoting the Phosphorylation of JNK and Induction of Endoplasmic Reticulum Stress Mediated by ROS in LO2 Cells. |
| Q47127745 | PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activity |
| Q52882603 | Pathogenesis of Nonalcoholic Steatohepatitis. |
| Q35928495 | Pathogenesis of nonalcoholic steatohepatitis |
| Q90722038 | Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells |
| Q89580537 | Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease |
| Q46468344 | Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats. |
| Q36320282 | Protective Effect of Enalapril against Methionine-Enriched Diet-Induced Hypertension: Role of Endoplasmic Reticulum and Oxidative Stress |
| Q90697527 | Protective Properties of FOXO1 Inhibition in a Murine Model of Non-alcoholic Fatty Liver Disease Are Associated With Attenuation of ER Stress and Necroptosis |
| Q58616514 | Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression |
| Q56979449 | Role of X-Box Binding Protein-1 in Fructose-Induced Lipogenesis in HepG2 Cells |
| Q89104306 | Role of cAMP and phosphodiesterase signaling in liver health and disease |
| Q94560928 | Safflower Yellow and Its Main Component HSYA Alleviate Diet-Induced Obesity in Mice: Possible Involvement of the Increased Antioxidant Enzymes in Liver and Adipose Tissue |
| Q89848670 | Suppression of IRE1α Attenuated the Fatty Degeneration in Parenteral Nutrition-Related Liver Disease (PNALD) Cell Model |
| Q47775932 | Testosterone Protects High Fat/Low Carbohydrate Diet Induced Non-Alcoholic Fatty Liver Disease in Castrated Male Rats Mainly via Modulating ER Stress |
| Q91639972 | The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats |
| Q92712205 | The Liver in Children With Metabolic Syndrome |
| Q50673306 | The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation. |
| Q37552230 | The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease |
| Q60924142 | The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q42367659 | Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis |
| Q55411030 | Unveiling “Musica Universalis” of the Cell: A Brief History of Biological 12-Hour Rhythms. |
| Q38893853 | p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer |
Search more.